4Suppliers
7Customers
2Debt Items
0Related Chains

Source-Backed Evidence Depth

Silo Pharma, Inc. (SILO) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

23Total relationships
3Distinct source URLs
17High confidence
0.850Average confidence
2026-09-13Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Silo Pharma, Inc. Suppliers

TickerNameConfidenceEvidence
BLIND-FAITH-CONCEPTS-HOLDINGS-INC BLIND-FAITH-CONCEPTS-HOLDINGS-INC 92% On September 29, 2018, we entered into an Asset Purchase Agreement with Blind Faith Concepts Holdings, Inc. pursuant to which we completed the acquisition of 100% of the assets of NFID from the seller
MANY-ADS-INC MANY-ADS-INC 92% Pursuant to the Agreement, the Seller agreed to sell, and the Company agreed to purchase, certain software of the web-based application currently marketed as "QwikAgents"
COLUMBIA-UNIVERSITY COLUMBIA-UNIVERSITY 90% During a one-year period from the date of this agreement, we shall pay a total of $1,436,082 to Columbia University for the support of the research
ONE-LICENSOR ONE-LICENSOR 90% For the three months ended March 31, 2026 and 2025, one licensor accounted for 100 % of the Company's vendor license agreements (see Note 8) related to the Company's biopharmaceutical operations.

Silo Pharma, Inc. Customers

TickerNameConfidenceEvidence
ONE-LICENSEE ONE-LICENSEE 90% For the three months ended March 31, 2026 and 2025, one licensee accounted for 100 % total revenues from customer license fees.
AIKIDO-PHARMA-INC AIKIDO-PHARMA-INC 62% alance sheets. The Right shall be, to the full extent permitted by and on terms and conditions required by UMB, for a term consistent with the term of patent and technology licenses that UMB normally…
BLIND-FAITH-CONCEPTS-HOLDINGS-INC BLIND-FAITH-CONCEPTS-HOLDINGS-INC 62% ent companies under the Investment Company Act (“Investment Company Accounting”) which applied to prior periods. We determined that there is no cumulative effect of the change from Investment Company…
CO-LLC CO-LLC 62% 0.75 per share, are exercisable immediately upon issuance and will expire five years from the effective date of a registration statement registering for resale the underlying October 2025 Warrant Sha…
MANY-ADS-INC MANY-ADS-INC 62% alance sheets. The Right shall be, to the full extent permitted by and on terms and conditions required by UMB, for a term consistent with the term of patent and technology licenses that UMB normally…
NFID-LLC NFID-LLC 62% ent companies under the Investment Company Act (“Investment Company Accounting”) which applied to prior periods. We determined that there is no cumulative effect of the change from Investment Company…
SILO-PHARMA-INC SILO-PHARMA-INC 62% nts of its type. In addition, the MAVS agreed to indemnify the Company for any misrepresentation or breach under the MAVS Agreement, infringement of any third-party right by any portion of the softwa…

Silo Pharma, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
SILO-DEBT-12532 Warrants outstanding: 250000 90% xbrl warrant detail from xbrl 2026-03-31.
SILO-DEBT-12533 Xbrl Convertible 90% xbrl convertible detail from xbrl 2020-12-31.

Silo Pharma, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Silo Pharma, Inc..

Silo Pharma, Inc. Ownership

HolderNameConfidenceEvidence
SILO-OWNER-GEODE-CAPITAL-MANAGEMENT-LLC Geode Capital Management, LLC 95% 13F/ownership overlay lists Geode Capital Management, LLC; shares held 92,905; ownership 0.09%; value $33,055; as of 2025-12-31.
SILO-OWNER-STATE-STREET-CORPORATION State Street Corporation 95% 13F/ownership overlay lists State Street Corporation; shares held 12,500; ownership 0.01%; value $4,447; as of 2025-12-31.
SILO-OWNER-SUSQUEHANNA-INTERNATIONAL-GROUP-LLP Susquehanna International Group, LLP 95% 13F/ownership overlay lists Susquehanna International Group, LLP; shares held 29,577; ownership 0.03%; value $10,523; as of 2025-12-31.
SILO-OWNER-ADVISORSHARES-INVESTMENTS-LLC AdvisorShares Investments, LLC 95% 13F/ownership overlay lists AdvisorShares Investments, LLC; shares held 599,507; ownership 0.60%; value $213,304; as of 2025-12-31.
SILO-OWNER-XTX-TOPCO-LTD Xtx Topco Ltd 95% 13F/ownership overlay lists Xtx Topco Ltd; shares held 56,899; ownership 0.06%; value $20,244; as of 2025-12-31.
SILO-OWNER-VANGUARD-GROUP-INC Vanguard Group Inc 95% 13F/ownership overlay lists Vanguard Group Inc; shares held 24,321; ownership 0.02%; value $8,653; as of 2025-12-31.
SILO-OWNER-VIRTU-FINANCIAL-LLC Virtu Financial LLC 95% 13F/ownership overlay lists Virtu Financial LLC; shares held 18,418; ownership 0.02%; value $6,553; as of 2025-12-31.
SILO-OWNER-UBS-GROUP-AG UBS Group AG 95% 13F/ownership overlay lists UBS Group AG; shares held 6,043; ownership 0.01%; value $2,150; as of 2025-12-31.
SILO-OWNER-DRW-SECURITIES-LLC DRW Securities, LLC 95% 13F/ownership overlay lists DRW Securities, LLC; shares held 333,733; ownership 0.34%; value $118,742; as of 2025-12-31.
SILO-OWNER-JANE-STREET-GROUP-LLC Jane Street Group, LLC 95% 13F/ownership overlay lists Jane Street Group, LLC; shares held 34,373; ownership 0.03%; value $12,229; as of 2025-12-31.

Silo Pharma, Inc. Extended Supply Chain Network

No secondary connectionsNo correlated companies found through shared supply chain relationships.
🔐
SILO
Unlock SILO Supply Chain Data
Verified relationships include:
BLIND-FAITH-CONCEPTS-HOLDINGS-INCBLIND-FAITH-CONCEPTS-HOLD…Supplier92%
MANY-ADS-INCMANY-ADS-INCSupplier92%
ONE-LICENSEEONE-LICENSEECustomer90%
AIKIDO-PHARMA-INCAIKIDO-PHARMA-INCCustomer62%
+19 more relationships locked
Subscribe — View plans →